5 research outputs found
Unraveling the genetic complexities of combined retinal dystrophy and hearing impairment.
Usher syndrome, the most prevalent cause of combined hereditary vision and hearing impairment, is clinically and genetically heterogeneous. Moreover, several conditions with phenotypes overlapping Usher syndrome have been described. This makes the molecular diagnosis of hereditary deaf-blindness challenging. Here, we performed exome sequencing and analysis on 7 Mexican and 52 Iranian probands with combined retinal degeneration and hearing impairment (without intellectual disability). Clinical assessment involved ophthalmological examination and hearing loss questionnaire. Usher syndrome, most frequently due to biallelic variants in MYO7A (USH1B in 16 probands), USH2A (17 probands), and ADGRV1 (USH2C in 7 probands), was diagnosed in 44 of 59 (75%) unrelated probands. Almost half of the identified variants were novel. Nine of 59 (15%) probands displayed other genetic entities with dual sensory impairment, including Alström syndrome (3 patients), cone-rod dystrophy and hearing loss 1 (2 probands), and Heimler syndrome (1 patient). Unexpected findings included one proband each with Scheie syndrome, coenzyme Q10 deficiency, and pseudoxanthoma elasticum. In four probands, including three Usher cases, dual sensory impairment was either modified/aggravated or caused by variants in distinct genes associated with retinal degeneration and/or hearing loss. The overall diagnostic yield of whole exome analysis in our deaf-blind cohort was 92%. Two (3%) probands were partially solved and only 3 (5%) remained without any molecular diagnosis. In many cases, the molecular diagnosis is important to guide genetic counseling, to support prognostic outcomes and decisions with currently available and evolving treatment modalities
Further evidence for loss-of-function mutations in the CEACAM16 gene causing nonsyndromic autosomal recessive hearing loss in humans
Diverse Metabolic Capacities of Fungi for Bioremediation
Bioremediation refers to cost-effective and
environment-friendly method for converting the toxic,
recalcitrant pollutants into environmentally benign products
through the action of various biological treatments.
Fungi play a major role in bioremediation owing to their
robust morphology and diverse metabolic capacity. The
review focuses on different fungal groups from a variety of
habitats with their role in bioremediation of different toxic
and recalcitrant compounds; persistent organic pollutants,
textile dyes, effluents from textile, bleached kraft pulp,
leather tanning industries, petroleum, polyaromatic hydrocarbons,
pharmaceuticals and personal care products, and
pesticides. Bioremediation of toxic organics by fungi is the
most sustainable and green route for cleanup of contaminated
sites and we discuss the multiple modes employed by
fungi for detoxification of different toxic and recalcitrant
compounds including prominent fungal enzymes viz.,
catalases, laccases, peroxidases and cyrochrome P450
monooxygeneses. We have also discussed the recent
advances in enzyme engineering and genomics and
research being carried out to trace the less understood
bioremediation pathways